Medical Equipment

Global Circulating Tumor Cells Industry Trends: Where the Market Is Headed by 2029

November 17, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Circulating Tumor Cells Market Size Likely To Evolve From 2025 Through 2034?

The market encompassing circulating tumor cells has experienced swift expansion lately; projections show it advancing from a valuation of $11.9 billion in 2024 to $13.27 billion by 2025, reflecting an 11.5% compound annual growth rate. This historical upswing is powered by several factors, including the rising frequency and widespread occurrence of cancer, the value of these cells in determining cancer progression stages, the development of liquid biopsy techniques, the preference among patients for procedures that involve less invasiveness, supportive actions from regulatory bodies regarding liquid biopsies, and a concentrated effort towards identifying cancer much earlier.

Projections indicate that the market for circulating tumor cells is poised for swift expansion in the forthcoming years, escalating to a valuation of $21.38 billion by 2029, driven by a compound annual growth rate (CAGR) of 12.7%.This forthcoming growth is fundamentally supported by several key factors, such as the burgeoning use of CTC testing at the point of care, increasing incorporation of microfluidic technologies, a heightened concentration on less common cancer categories, the effort to standardize various CTC assay procedures, the proliferation of clinical trials utilizing CTCs, and expansion within both developed and burgeoning economies.Significant developments anticipated throughout this forecast duration encompass novel developments in isolating circulating tumor cells, increased governmental financial support channeled toward CTC investigation, progress in the methods used to identify these cells, the utilization of liquid biopsy for ongoing cancer surveillance, the merging of CTC analysis with resolution at the single-cell level, and the technological synergy realized by integrating artificial intelligence (AI).

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Which Drivers Are Shaping The Circulating Tumor Cells Industry’s Market Share?

The escalating frequency of cancer cases is projected to be a key catalyst for the expansion of the market for circulating tumor cells in the foreseeable future. Cancer, fundamentally characterized by the uncontrolled proliferation and subsequent dissemination of certain bodily cells, relies on circulating tumor cell technologies for its early identification and accurate diagnosis, thereby directly fueling market expansion as cancer rates rise. To illustrate this trend, data provided in January 2023 by the American Cancer Society Journals, a prominent US non-profit health entity, indicated an anticipation of 1,958,310 new cancer diagnoses and an estimated 609,820 cancer fatalities within the United States, underscoring why the increasing prevalence of cancer strongly motivates the growth trajectory of the circulating tumor cells market.

What Are The Primary Types Of Segments Analyzed In The Circulating Tumor Cells Market?

The circulating tumor cellsmarket covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

What Are The Major Trends Driving The Growth Of The Circulating Tumor Cells Market?

A significant movement within the circulating tumor cells sector involves advancements in product offerings. Leading firms actively participating in this market are concentrating their efforts on engineering novel solutions to solidify their competitive standing. Demonstrating this drive, in the month of June in 2024, Bio-Rad Laboratories, Inc., an American firm specializing in medical diagnostics, introduced the Celselect Slides 2.0, a device engineered specifically to boost the isolation of scarce cells and circulating tumor cells, consequently boosting the precision and effectiveness of cell evaluation for both medical practice and scientific inquiry.

Who Are The Core Companies Influencing The Circulating Tumor Cells Market Landscape?

Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Region Is Projected To Lead The Circulating Tumor Cells Market During The Forecast Period?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Circulating Tumor Cells Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Browse Through More Reports Similar to the Global Circulating Tumor Cells Market 2025, By The Business Research Company

Cardiovascular Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Surgery Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-surgery-devices-and-equipment-global-market-report

Spinal Surgery Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/spinal-surgery-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795